Drug Cost Management Report - Johnson & Johnson’s popular epilepsy drug Topamax is showing promise as a treatment for migraine headaches - topiramate - Product News in Brief
Tuesday, September 9th, 2008* Johnson & Johnson’s popular epilepsy drug Topamax (topiramate) is showing promise as a treatment for migraine headaches. The company announced it will seek additional FDA approval for Topamax to be used as a preventive therapy for migraines. Topamax is currently approved to treat epileptic seizures as an adjunctive therapy, and the company is seeking further FDA approval for the drug to be used as a monotherapy for epilepsy.
Most Popular
10 Jobs …
